Lung cancer and normal cell lines

Transcription

1 The Essentials of Life Science Research Globally Delivered Lung and normal cell lines ATCC No. Name Tissue Cell Type Disease Oganism Age Ethnicity Genes Expressed CRL-5844 NCI-H838 [H838] 3B, adenocarcinoma; non-small CRL-2868 HCC827 epithelial adenocarcinoma 59 yrs 39 years HTB-57 SK-LU-1 adenocarcinoma 60 years CRL-2869 CRL-2871 CRL-5897 HTB-179 HTB-55 HCC2935 HCC4006 NCI-H1819 [H1819] NCI-H676B [H676B] Calu-3 /pleural epithelial adenocarcinoma 39 years epithelial adenocarcinoma greater than 50 years adenocarcinoma 55 years adenocarcinoma 63 years mucin adenocarcinoma 25 years Blood Type A; Rh+ CRL-7380 Hs 618.T adenocarcinoma 60 years CRL-2078 CRL-5885 HBE4-E6/E7 [NBE4-E6/E7] NCI-H1666 [H- 1666, H1666] CRL-5800 NCI-H23 [H23] CRL-5870 CRL-5875 NCI-H1435 [H1435] NCI-H1563 [H1563] /bronchus epithelial Adenocarcinoma, Papilloma 60 years adenocarcinoma; bronchoalveolar carcinoma 50 years Blood Type O; Rh+; HLA Aw24, Aw32, B27, Bw41 51 years Black myc +; src +; abl +; erb +; ras +; sis - 35 years

2 CRL-5884 CRL-5891 CRL-5896 CRL-5899 CRL-5908 CRL-5921 CRL-5935 CRL-5876 CRL-5914 CRL-5939 CCL-256 NCI-H1651 [H1651] NCI-H1734 [H- 1734, H1734] NCI-H1793 [H1793] NCI-H1838 [H1838] NCI-H1975 [H- 1975, H1975] NCI-H2085 [H2085] NCI-H2228 [H2228] NCI-H1568 [H1568] NCI-H2030 [H2030] NCI-H2291 [H2291] NCI-H2126 [H2126] 71 years 56 years 52 years 45 years 48 years 65 years CCL-196 LA-4 adenoma Mus musculus 28 weeks HTB-178 NCI-H596 [H596] adenosquamous carcinoma 73 years CRL-2170 SW 1573 [SW- 1573, SW1573] alveolar cell carcinoma 44 years Blood Type O; Rh + CCL-204 CCD-16Lu fibroblast Astrocytoma 35 years CRL-5838 NCI-H720 [H720] atypical carcinoid CRL-2081 MSTO-211H biphasic mesothelioma 62 years CRL-5807 CRL-5835 NCI-H358 [H- 358, H358] NCI-H650 [H650] /bronchiole; alveolus bronchioalveolar carcinoma; nonsmall bronchioalveolar carcinoma; nonsmall CRL-7194 Hs 229.T bronchogenic adenocarcinoma 65 years HTB-168 ChaGo-K-1 /bronchus bronchogenic carcinoma 45 years CRL-7343 Hs 573.T 71 years Blood type A; Rh+ CRL-7344 Hs 573.Lu Cancer 71 years Blood type A; Rh+ c-myc +; v-src +; v-abl +; v-erb B +; c-raf 1 +; H-ras +; K-ras +; N-ras +; N-myc -; L-myc -; c-myb -; c-fos -; v-fes -; v-fms -; v-sis - surfactant associated protein A (SP-A), The cells expressed protein and RNA of SP-A, the major surfactant associated protein. hcg; human chorionic gonadotropin (alpha subunit only); estradiol; progesterone; mucin (apomucin, MUC-1, MUC-2) 2 Order online at call , , or contact your local distributor.

3 HB D4 Lung, spleen, Lung, Tissue hybridoma: B lymphocyte Cancer, Cancer Mus musculus CRL-9482 BBM /bronchus Carcinogen CRL-9483 BZR /bronchus Carcinogen CRL-5843 NCI-H835 [H835] carcinoid 48 years Black CRL-5975 UMC-11 carcinoid neuromedin B immunoglobulin; monoclonal antibody; against human CRL-5815 NCI-H727 [H727] /bronchus carcinoid 65 years neuromedin B (NMB) CCL-185 A549 Carcinoma 58 years CCL-200 CCD-13Lu fibroblast Carcinoma 71 years Black HTB-53 A-427 carcinoma 52 years PTS-CCL-185 A549 Carcinoma 58 years CRL H8 Lung, spleen hybridoma: B lymphocyte Carcinoma Mus musculus CCL-257 CRL-5804 HTB-183 HTB-177 CRL-5803 CRL-5818 NCI-H1688 [H1688] NCI-H187 [H187] NCI-H661 [H661] NCI-H460 [H460] NCI-H1299 NCI-H1155 [H1155] Retinoblastoma carcinoma; classic small cell carcinoma; classic small cell 50 years 47 years c-kit +; N-myc + carcinoma; large 43 years carcinoma; large carcinoma; non-small cell carcinoma; non-small cell 43 years The cells are positive for keratin by immunoperoxidase staining. keratin, The cells are positive for keratin by immunoperoxidase staining. immunoglobulin; monoclonal antibody; against periostin 36 years neuromedin B (NMB) CRL-2066 DMS 114 carcinoma; small 68 years HTB-119 NCI-H69 [H69] carcinoma; small 55 years CRL-2049 DMS 79 carcinoma; small 65 years neuromedin B, The cells have a homozygous partial deletion of the p53 protein, and lack expression of p53 protein. adrenocorticotropin (adrenocorticotropic hormone, ACTH); bombesin; glucagon; 17 beta estradiol; oxytocin - neurophysin (OT-NP), Leu 7 +; My23 +; CD11b + myc +; myb +; fes +; fms +; raf +; ras + adrenocorticotropin (adrenocorticotropic hormone, ACTH); bombesin; calcitonin; corticotropin; beta endorphin; 17 beta estradiol; lipotropin; oxytocin - neurophysin (OT-NP); parathormone; somatostatin-like immunoreactivity (SRIF), c-myc +; N-myc +; c-raf-1 +; H-ras +; K-ras +; N-ras +; v-fes -; v-fms -, Leu 7; My23 Order online at call , , or contact your local distributor. 3

4 CRL-2062 DMS 53 carcinoma; small 54 years CRL-2177 SW 1271 [SW- 1271, SW1271] carcinoma; small 69 years Blood Type A; Rh + CRL-2195 SHP-77 epithelial carcinoma; small 54 years HTB-172 HTB-173 HTB-180 CRL-5864 NCI-H209 [H209] NCI-H146 [H146] NCI-H345 [H345] NCI-H1341 [H1341] : bone : bone : bone adrenocorticotropin (adrenocorticotropic hormone, ACTH); bombesin; calcitonin; human chorionic gonadotropin (hcg); glucagon; growth hormone; 17 beta estradiol; thyroid releasing hormone; oxytocin - neurophysin (OT-NP); parathormone;, somatostatin-like immunoreactivity (SRIF), Leu 7; My23 neural cell adhesion molecule (NCAM) NKH-1, Blood Type O; Rh +; CD56; CD57 (HNK-1, Leu-7) carcinoma; small prb + (abnormal, RB1) Epithelial carcinoma; small 59 years carcinoma; small : cervix carcinoma; small 64 years CRL-2064 DMS 153 : liver carcinoma; small 44 years HTB-175 CRL-5853 HTB-120 HTB-171 NCI-H82 [H82] NCI-H1048 [H1048] NCI-H128 [H128] NCI-H446 [H446] The cells do not express vasopressin, oxytocin or gastrin releasing peptide. gastrin releasing peptide adrenocorticotropin (adrenocorticotropic hormone, ACTH); bombesin; calcitonin; calcitonin gene related peptide (CGRP); oxytocin - neurophysin (OT-NP); 17 beta estradiol, Leu 7 +; My23 +; CD11b + carcinoma; small 40 years myc +; myb -; raf +; ras +; fms +; fes + carcinoma; small carcinoma; small 60 years Black carcinoma; small 61 years CCL-258 NCI-H128 [H128] carcinoma; small HTB-184 NCI-H510A [H510A, NCI-H510] : adrenal gland CRL H69AR epithelial carcinoma; small ; extrapulmonary origin carcinoma; small ; multidrug resistant 56 years 55 years CCL-199 HLF-a epidermoid carcinoma 54 years Black CRL-7668 Hs 913(F).T or bronchus fibrosarcoma 51 years HTB-152 Hs 913T fibrosarcoma 51 years TIB-223 GCT [Giant Cell Tumor] fibrous histiocytoma 29 years colony stimulating activity (CSA); erythroid enhancing activity (EEA); prostaglandin E; plasminogen activator 4 Order online at call , , or contact your local distributor.

5 CCL-64 Mv 1 Lu (NBL-7) focus forming assays for murine and feline sarcoma viruses [PubMed: ]. CCL-195 AHL-1 genetic toxicology studies. Neovison vison CCL-215 CCD-25Lu fibroblast Glioma 7 years HTB-54 Calu-1 : pleura grade III, epidermoid carcinoma 47 years Blood Type A; Rh+; HLA A10, A11, B15, Bw35 HTB-59 SW 900 [SW-900, SW900] grade IV, squamous cell carcinoma near term fetus 53 years CRL-1642 LL/2 (LLC1) Lewis carcinoma Mus musculus H-2b CRL-2741 HBE135-E6E7 /bronchus epithelial HTB-106 Tera-2 malignant embryonal carcinoma 22 years Blood Type A; Rh+ CRL-1848 NCI-H292 [H292] mucoepidermoid pulmonary carcinoma CRL-2885 snf02.2 Lung Schwann Cell neurofibrmatosis type 1 (NF1) CRL-5889 CRL-5930 CRL-5945 CRL-5924 CRL-5926 NCI-H1703 [H1703] NCI-H2172 [H2172] NCI-H2444 [H2444] NCI-H2110 [H2110] NCI-H2135 [H2135] squamous cell non-small non-small non-small non-small 54 years 32 years Black non-small 35 year old 54 years CCL-137 HEL 299 fibroblast Normal fetus Black CCL-171 MRC-5 fibroblast Normal CCL-186 IMR-90 fibroblast normal 14 weeks 16 weeks CCL-210 CCD-19Lu fibroblast Normal 20 years CCL-212 MRC-9 fibroblast Normal CCL-75 WI-38 fibroblast normal CRL-9609 BEAS-2B /bronchus epithelial normal 15 weeks 3 months fetus CCL-206 MLg [Mlg 2908] normal Mus musculus newborn keratin; vimentin, The cells retain their mucoepidermoid characteristics in culture as determined by their ultrastructure and expression of multiple markers of squamous differentiation. Order online at call , , or contact your local distributor. 5

6 CRL-2192 NR8383 [AgC11x3A, NR8383.1] macrophage (alveolar) normal Rattus norvegicus CCL-211 Hs888Lu fibroblast Osteosarcoma 20 years CRL-7624 Hs 888.Lu Osteosarcoma 20 years CRL-2837 K7M2-pCI Neo osteoblast osteosarcoma Mus musculus HTB-174 NCI-H441 [H441] papillary adenocarcinoma CRM- HTB-174 CRM-HTB- 174D CRL-5819 HTB-181 NCI-H441 [H441] papillary adenocarcinoma NCI-H441 [H441] papillary adenocarcinoma NCI-H1404 [H1404] NCI-H820 [H820] papillary adenocarcinoma 48 years papillary adenocarcinoma 53 years CCL-190 LL 86 (LeSa) fibroblast sarcoma 18 years CCL-64.1 MiCl1 (S+L-) sarcoma Mus musculus CRL-7037 Hs 57.T sarcoma or lymphoma 22 years Black CRL-5928 NCI-H2170 [H2170] squamous cell carcinoma HTB-182 NCI-H520 [H520] squamous cell carcinoma HTB-58 SK-MES-1 squamous cell carcinoma near term 65 years CRL-2182 EPLC-32M1 squamous cell carcinoma 68 years CRL-1453 KLN 205 squamous cell carcinoma Mus musculus CRL-5826 CRL-5942 CRL-5922 CRL-5872 CRL-5917 NCI-H226 [H226] NCI-H2347 [H2347] NCI-H2087 [H2087] NCI-H1437 [H1437] NCI-H2066 [H2066] squamous cell carcinoma; mesothelioma stage 1, adenocarcinoma; nonsmall stage 1, adenocarcinoma; nonsmall stage 1, adenocarcinoma; nonsmall stage 1, mixed; small cell ; adenocarcinoma; squamous cell carcinoma 54 years 69 years 60 years 70 years transforming growth factor beta (TGF beta); interleukin 1 (IL-1); interleukin 6 (IL-6) decorin, secreted phosphoprotein 1 (osteopontin), villin 2 (ezrin), Expression of bone sialoprotein, biglyan, decorrin, and osteopontin is suggestive of bone lineage cells. surfactant associated protein A (SP-A); surfactant associated protein B (SP-B) Blood Type O; Rh+; HLA A3, Aw30, B7, B27 human chorionic gonadotropin alpha subunit (hcg alpha), myc + 6 Order online at call , , or contact your local distributor.

7 CRL-5938 CRL-5868 NCI-H2286 [H2286] NCI-H1395 [H1395] CRL-5810 NCI-H522 [H522] CRL-5816 NCI-H810 [H810] CRL-5882 CRL-5918 CRL-5941 CRL-5909 CRL-5912 CRL-5834 CRL-5867 CRL-5881 CRL-5907 CRL-5883 CRL-5894 CRL-5887 CRL-5895 CRL-5911 CRL-5865 CRL-5877 CRL-5944 CRL-5892 NCI-H1648 [H1648] NCI-H2073 [H2073] NCI-H2342 [H2342] NCI-H1993 [H1993] NCI-H2023 [H2023] NCI-H647 [H647] NCI-H1385 [H1385] NCI-H1623 [H1623] NCI-H1944 [H1944] NCI-H1650 [H- 1650, H1650] NCI-H1781 [H1781] NCI-H1693 [H1693] NCI-H1792 [H1792] NCI-H2009 [H2009] NCI-H1355 [H1355] NCI-H1573 [H1573] NCI-H2405 [H2405] NCI-H1755 [H1755] stage 1, mixed; small cell ; adenocarcinoma; squamous cell carcinoma 57 years stage 2, adenocarcinoma 55 years : soft tissue stage 2, adenocarcinoma; nonsmall stage 2, carcinoma; non-small cell 58 years 51 years Black stage 3A, adenocarcinoma 39 years Black stage 3A, adenocarcinoma; nonsmall stage 3A, adenocarcinoma; nonsmall stage 3A, adenocarcinoma; nonsmall stage 3A, adenocarcinoma; nonsmall stage 3A, adenosquamous carcinoma; non-small cell stage 3A, carcinoma; non-small stage 3B, adenocarcinoma; nonsmall stage 3B, adenocarcinoma; nonsmall stage 3B, adenocarcinoma; bronchoalveolar carcinoma stage 3B, adenocarcinoma; bronchoalveolar carcinoma stage 3B, adenocarcinoma; nonsmall 47 years 55 years 47 years 26 years 56 years 49 years Black 58 years 62 years 27 years, 66 years 55 years stage 4, adenocarcinoma 50 years stage 4, adenocarcinoma 68 years stage 4, adenocarcinoma 53 years : soft tissue stage 4, adenocarcinoma 35 years : ascites : liver stage 4, adenocarcinoma; nonsmall stage 4, adenocarcinoma; nonsmall 47 years 65 years Order online at call , , or contact your local distributor. 7

8 CRL-5850 CRL-5985 CRL-5893 CRL-5878 CRL-5923 CRL-5900 CRL-5904 CRL-5817 CRL-5869 CRL-5888 CRL-5837 CRL-5855 NCI-H920 [H920] NCI-H2122 [H2122] NCI-H1770 [H1770] NCI-H1581 [H1581] NCI-H2106 [H2106] NCI-H1869 [H1869] NCI-H1915 [H1915] NCI-H889 [H889] NCI-H1417 [H1417] NCI-H1694 [H1694] NCI-H719 [H719] NCI-H1092 [H1092] / neuroendocrine: lymph : brain : ascites : bone : bone CRL-5828 NCI-H250 [H250] : brain CRL-5840 CRL-5856 CRL-5871 CRL-5902 CRL-5808 CRL-5920 NCI-H740 [H740] NCI-H1105 [H1105] NCI-H1436 [H1436] NCI-H1876 [H1876] NCI-H378 [H378] NCI-H2081 [H2081] CRL-5842 NCI-H774 [H774] : soft tissue CRL-5841 NCI-H748 [H748] neuroendocrine large cell squamous cell large cell stage 4, adenocarcinoma; nonsmall stage 4, adenocarcinoma; nonsmall stage 4, carcinoma; non-small cell stage 4, non-small cell stage 4, non-small cell stage 4, non-small cell stage 4, poorly differentiated carcinoma; non-small cell 43 years 46 years, 57 years 44 years 58 years 58 years 61 years 69 years 61 years 61 years 55 years 67 years 34 years Black 63 years 73 years 39 years 59 years 66 years c-kit +; L-myc + 59 years 43 years 62 years Black 8 Order online at call , , or contact your local distributor.

9 CRL-5825 CRL-5836 CRL-5934 CRL-5824 CRL-5859 CRL-5879 CRL-5903 CRL-5931 CRL-5932 CRL-5913 CRL-5927 CRL-5933 CRL-5929 NCI-H220 [H220] NCI-H711 [H711] NCI-H2227 [H2227] NCI-H211 [H211] NCI-H1238 [H1238] NCI-H1618 [H1618] NCI-H1882 [H1882] NCI-H2195 [H2195] NCI-H2196 [H2196] NCI-H2029 [H2029] NCI-H2141 [H2141] NCI-H2198 [H2198] NCI-H2171 [H2171] : bone : bone : bone : bone : bone : bone : bone CRL-5978 NCI-H735 [H735] : liver CRL-5976 CRL-5983 CRL-5984 CRL-5874 CRL-5811 CRL-5823 CRL-5886 CRL-5898 NCI-H64 [H64] NCI-H2107 [H2107] NCI-H2108 [H2108] NCI-H1522 [H1522] NCI-H526 [H526] NCI-H196 [H196] NCI-H1672 [H1672] NCI-H1836 [H1836] : bone : bone : bone epithelial stage E, carcinoma; variant small stage E, carcinoma; variant small stage L, carcinoma; classic small stage L, carcinoma; classic small 51 years Black 49 years 54 years 50 years, 64 years 55 years 59 years 67 years 67 years 69 years 58 years 67 years 50 years 58 years 48 years 36 years Black 36 years Black 53 years 55 years 68 years 58 years 52 years myc +; myb +; fes +; fms +; raf +; ras + Order online at call , , or contact your local distributor. 9

10 CRL-5906 CRL-5849 CRL-5846 CRL-5982 CRL-5858 CRL-5940 CRL-5831 CRL-5845 CRL-2401 NCI-H1930 [H1930] NCI-H865 [H865] NCI-H847 [H847] NCI-H1963 [H1963] NCI-H1184 [H1184] NCI-H2330 [H2330] NCI-H524 [H524] NCI-H841 [H841] anti-130-kda Mesothelial- Ciliated Cells Lung, mesothelia, Endometrium, epithelia hybridoma: B lymphocyte stage L, carcinoma; classic small stage L, carcinoma; classic small stage L, carcinoma; classic small stage L, carcinoma; small cell stage L, carcinoma; small cell stage L, carcinoma; small cell stage L, carcinoma; variant small stage L, carcinoma; variant small The diagnosis of epithelial mesotheliomas and ovarian/ endometrial carcinomas, because it selectively stains these tumors and is reactive with formalinfixed, paraffin-embedded tissues. 41 years 54 years 63 years, 56 years Black 42 years 57 years 63 years Mus musculus 51 years, CCL-134 LL 29 (AnHa) fibroblast 26 years CCL-135 LL 47 (MaDo) fibroblast 16 years Black CCL-40 Bu (IMR-31) Bison bison yearling CCL-158 JH4 clone 1 Cavia porcellus CCL-162 DBS-FCL-2 CRL MBr6 / bronchus epithelial CCL-161 DBS-FCL-1 CCL-16 Don CCL-39 Dede CCL-93 V79-4 CRL-1657 R 1610 CRL-1935 CHL/IU [CHL-11] CRL-2349 XR-V15B fibroblast Cercopithecus aethiops Cercopithecus aethiops Cercopithecus aethiops 141 days 2 to 3 years 135 days 8 months newborn immunoglobulin; monoclonal antibody; against the 130-kDa mesothelial and ciliated cell protein 10 Order online at call , , or contact your local distributor.

11 CRL-1921 NZP-12 Crossarchus obscurus CCL-150 AK-D Felis catus fetus CCL-217 Fc2Lu Felis catus CCL-151 LL 24 fibroblast 5 years CCL-153 HFL1 fibroblast fetus CCL-191 LL 97A (AlMy) fibroblast 48 years CCL-201 CCD-8Lu fibroblast 48 years blood type A; Rh + CCL-202 CCD-11Lu fibroblast 9 years Asian blood type O; Rh + CCL-205 CCD 18Lu fibroblast CCL-75.1 WI-38 VA-13 subline 2RA fibroblast CCL-95.1 WI-26 VA4 near term 2.5 months 3 months 3 month Black CRL-1490 CCD-33Lu fibroblast 7 years CRL-2886 snf94.3 Lung Schwann Cell CRL-7000 Hs 1.Lu fibroblast HTB-157 FHs 738Lu 43 year old second trimester second trimester HTB-64 Malme-3M fibroblast, Melanoma 43 years HLA A2, Aw30, B13, B40(+/-), DRw7 CRL-2079 HBE4-E6/E7-C1 [NBE4-E6/E7-C1] /bronchus epithelial 60 years CRL-1478 CCD-29Lu 80 years Black CRL-1491 CCD-34Lu fibroblast 2.5 weeks Black CRL-1498 CCD-39Lu 8 days CCL-111 Gekko -1 lizard, gecko (Gekko gecko) CL-160 DBS-FRhL-2 fibroblast Macaca mulatta fetus CCL-208 4MBr-5 /bronchus epithelial Macaca mulatta CCL-100 GeLu Meriones unguiculatus 2 to 3 years 403 days CRL-2019 MH-S macrophage (alveolar) Mus musculus 7 weeks CRL-2455 AMJ2-C8 macrophage (alveolar) Mus musculus 10 weeks old keratin, The cells are positive for keratin by immunoperoxidase staining. interleukin 1 (IL-1), CD11b (Mac-1); Class II antigens (I-A); T antigen MAC-1 (CD11b) +; MAC-2 +; Fc receptor (FcR) +; Ly-5 +; Thy-1 -; Lyt-1 - Order online at call , , or contact your local distributor. 11

12 CRL-2456 AMJ2-C11 macrophage (alveolar) Mus musculus CRL-2110 MLE 12 epithelial Mus musculus HB-8191 CRL-6382 alpha-ace [ACE 3.1.1, a-ace 3.1.1] MM14.Lu Lung, spleen, endothelia, endothelia or bronchus CCL-193 R9ab fibroblast hybridoma: B lymphocyte Mus musculus Mus musculus Oryctolagus cuniculus CRL-1925 NZP-29 Oryx dammah CCL-149 L2 CCL-192 RFL-6 fibroblast CRL RL-65 Squamous Epithelium, Epithelial CRL-2300 RLE-6TN alveolar type II CCL-194 DPSO 114/74 fibroblast CRL D4/21 macrophage macrophage (alveolar) Rattus norvegicus Rattus norvegicus Rattus norvegicus Rattus norvegicus Saimiri boliviensis peruviensis Sus scrofa 10 weeks old 5 month old fetus 18 days CRL D4/31 macrophage (alveolar)n Sus scrofa 27 days CRL D4/2 Lung CCL-88 Tb 1 Lu CCL-168 FoLu fibroblast macrophage macrophage (alveolar) Sus scrofa Tadarida brasiliensis Urocyon cineroargenteus 5 days 56 day old fetus 27 days 27 days interleukin-6 (interleukin 6, IL-6), MAC-1 (CD11b) +; MAC-2 +; Fc receptor (FcR) +; Ly-5 +; Thy-1 -; Lyt-1 -, Constitutive expression of MHC-class-II antigens was low on AMJ2-C11 but was increased following exposure to rmuifn-gamma. surfactant proteins B and C (SP-B, SP-C) immunoglobulin; monoclonal antibody; against angiotensin converting enzyme (ACE) cytoskeletal proteins (alpha keratin, actin, desmin, vimentin, tubulin); fibronectin; laminin cytokeratin 8 and 19, However, expression of the SV40-T antigen was negative by nuclear immunostaining and by PCR, indicating these cells were derived by a spontaneous immortalization., The cell line exhibits characteristics of alveolar Type II cells such as lipid-containing inclusion bodies (phosphine 3R staining and electron microscopy) and expression of cytokeratin 8 and 19; the cells do not express alkaline phosphatase activity., Expression of several chemotactic cytokines by RLE-6TN cells was found to release squirrel monkey retrovirus after co-cultivation with the canine thymus cell line A Order online at call , , or contact your local distributor.

13 CRL-2503 NL20 /bronchus Epithelial Accident victim 20 years CRL-2504 NL20-TA [NL20T-A] /bronchus Epithelial Accident victim 20 years,, PHONE WEB CB American Type Culture Collection. The ATCC trademark and trade name, any and all ATCC catalog numbers and any other trademarks listed in this publication are trademarks of the American Type Culture Collection unless indicated otherwise. These products are for laboratory use only. Not for human or diagnostic use. ATCC products may not be resold, modified for resale, used to provide commercial services or to manufacture commercial products without prior ATCC written approval.